Effects of amoxicillin-clavulanate combination on the motility of the small intestine in human beings
- PMID: 1929247
- PMCID: PMC284291
- DOI: 10.1128/AAC.35.6.1085
Effects of amoxicillin-clavulanate combination on the motility of the small intestine in human beings
Abstract
The amoxicillin-clavulanate combination (Augmentin) frequently induces gastric complaints and diarrhea by an unknown mechanism. The aim of this study was to assess the effects of two orally therapeutic regimens of amoxicillin-clavulanate on small bowel motility in human beings. Duodeno-jejunal manometric recordings were performed in six healthy subjects treated in a cross-over double-blind study with placebo; amoxicillin-clavulanate, 1 g plus 250 mg per os every 12 h for 3 days; or amoxicillin-clavulanate, 1 g plus 250 mg per os every 12 h on day 3 only (1-day regimen). Recordings were all performed on day 3 during a diurnal fasting period, a fed state after a standard dinner, and a nocturnal fasting period. Amoxicillin-clavulanate did not affect the motility of the small intestine during the diurnal fast or the fed state. During the nocturnal fast, amoxicillin-clavulanate significantly increased the motility index of the nonpropagated contractions and tended to increase the duration and the amplitude of the propagated contractions. The same digestive motor effect was already observed on the first day of treatment (1-day regimen). This study demonstrates that the oral administration of a therapeutic regimen of amoxicillin-clavulanate is associated, in most cases, with the occurrence of small intestinal motor disturbances.
Similar articles
-
[Augmentin].Antibiot Khimioter. 1992 Sep;37(9):3-9. Antibiot Khimioter. 1992. PMID: 1444667 Review. Russian. No abstract available.
-
Effect of amoxicillin/clavulanate on gastrointestinal motility in children.J Pediatr Gastroenterol Nutr. 2012 Jun;54(6):780-4. doi: 10.1097/MPG.0b013e31824204e4. J Pediatr Gastroenterol Nutr. 2012. PMID: 22584747 Clinical Trial.
-
Equivalent efficacy and reduced occurrence of diarrhea from a new formulation of amoxicillin/clavulanate potassium (Augmentin) for treatment of acute otitis media in children.Pediatr Infect Dis J. 1997 May;16(5):463-70. doi: 10.1097/00006454-199705000-00002. Pediatr Infect Dis J. 1997. PMID: 9154538 Clinical Trial.
-
Treatment of gonorrhea with clavulanate-potentiated amoxicillin (Augmentin).Sex Transm Dis. 1985 Jul-Sep;12(3):163-5. doi: 10.1097/00007435-198507000-00015. Sex Transm Dis. 1985. PMID: 3929409 Clinical Trial.
-
Amoxicillin-potassium clavulanate: a novel beta-lactamase inhibitor.Drug Intell Clin Pharm. 1985 Jun;19(6):415-20. doi: 10.1177/106002808501900601. Drug Intell Clin Pharm. 1985. PMID: 3891282 Review.
Cited by
-
[Antibiotic induced diarrhea and pseudomembranous colitis].Urologe A. 2003 Jan;42(1):82-9; discussion 87. doi: 10.1007/s00120-002-0267-2. Epub 2002 Dec 19. Urologe A. 2003. PMID: 12574886 German.
-
Gastroesophageal Reflux Disease and Foregut Dysmotility in Children with Intestinal Failure.Nutrients. 2020 Nov 18;12(11):3536. doi: 10.3390/nu12113536. Nutrients. 2020. PMID: 33217928 Free PMC article. Review.
-
Effects of two oral erythromycin ethylsuccinate formulations on the motility of the small intestine in human beings.Antimicrob Agents Chemother. 1996 Aug;40(8):1796-800. doi: 10.1128/AAC.40.8.1796. Antimicrob Agents Chemother. 1996. PMID: 8843283 Free PMC article. Clinical Trial.
-
Antibiotic-Associated Diarrhea Beyond C. Difficile: A Scoping Review.Brown J Hosp Med. 2022 Nov 1;2(1):39745. doi: 10.56305/001c.39745. eCollection 2023. Brown J Hosp Med. 2022. PMID: 40046540 Free PMC article.
-
Probiotics in the prevention of antibiotic-associated diarrhoea and Clostridium difficile infection.Therap Adv Gastroenterol. 2011 May;4(3):185-97. doi: 10.1177/1756283X11399115. Therap Adv Gastroenterol. 2011. PMID: 21694803 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical